SkinCancer360

The first and only FDA-approved immunotherapy for this patient population October 8, 2025 (Sacramento, California) The FDA has approved the…

Visiting an oncologist for the first time can feel overwhelming. Whether you are transitioning from dermatology care or have recently…

Understanding Skin Cancer in Older Veterans Veterans have dedicated their lives to serving our nation, often enduring long hours of…

Understanding why skin cancer develops—and how to better prevent and treat it—is at the heart of modern research. In a…

Learn about Merkel cell carcinoma, a rare skin cancer, its risk factors, diagnosis, and how new immunotherapies are improving outcomes.…

A skin cancer diagnosis often brings with it a clear medical path—surgery, treatment, follow-up. But what’s less discussed is the…

Does Price Influence Sunscreen Use? A Closer Look at the Data The cost of sunscreen could be undermining proper usage,…

Males over the age of 65 years are experiencing a tremendous and growing increase in nonmelanoma skin cancers, according to…

Patients with cutaneous squamous cell carcinoma treated with cemiplimab (brand name LIBTAYO) had longer disease-free survival than patients treated with…

Q&A with Dr. Neil D. Gross, MD, FACS Dr. Neil D. Gross, M.D., FACS, is a professor, scientist, and surgeon…